HYFTOR is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Nobelpharma America, Llc. The primary component is Sirolimus.
| Product ID | 73683-101_dbdaca4e-b55c-7d41-e053-2995a90abb9a |
| NDC | 73683-101 |
| Product Type | Human Prescription Drug |
| Proprietary Name | HYFTOR |
| Generic Name | Sirolimus |
| Dosage Form | Gel |
| Route of Administration | TOPICAL |
| Marketing Start Date | 2022-03-23 |
| Marketing Category | NDA / |
| Application Number | NDA213478 |
| Labeler Name | Nobelpharma America, LLC |
| Substance Name | SIROLIMUS |
| Active Ingredient Strength | 2 mg/g |
| Pharm Classes | Decreased Immunologic Activity [PE], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA], mTOR Inhibitor Immunosuppressant [EPC], mTOR Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-03-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0008-1030 | Rapamune | SIROLIMUS |
| 0008-1040 | Rapamune | SIROLIMUS |
| 0008-1041 | Rapamune | SIROLIMUS |
| 0008-1042 | Rapamune | SIROLIMUS |
| 0904-7147 | sirolimus | sirolimus |
| 0904-7248 | Sirolimus | Sirolimus |
| 13668-658 | Sirolimus | Sirolimus |
| 16714-187 | sirolimus | sirolimus |
| 16714-188 | sirolimus | sirolimus |
| 16714-189 | sirolimus | sirolimus |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() HYFTOR 88600269 not registered Live/Pending |
Nobelpharma Co., Ltd. 2019-08-30 |